Source: Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yukyee Wu, John Wharton, Rachel Walters, Eleni Vasilaki, Jurjan Aman, Lan Zhao, Martin R. Wilkins, Christopher J. Rhodes. The pathophysiological role of novel pulmonary arterial hypertension gene SOX17. Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020

Member's Comments

No comment yet.

Related content which might interest you: CFTR involvement in the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006 Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension Source: Annual Congress 2007 - Pulmonary hypertension Year: 2007 Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020 Year: 2021 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 A novel piperidine attenuates pulmonary arterial hypertension via regulating BMP2 and PTGS2 levels Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Survivin inhibition as a potential target for pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Expression of fetal genes in pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 The emerging role of epigenetics in pulmonary hypertension Source: Eur Respir J 2016; 48: 903-917 Year: 2016 Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Targeting HIF2a-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension Source: Eur Respir J, 57 (3) 1902061; 10.1183/13993003.02061-2019 Year: 2021 The dual role of apoptosis in pulmonary hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels Source: Eur Respir J, 51 (4) 1702229; 10.1183/13993003.02229-2017 Year: 2018 Hypoxia-induced miR-130a is a novel repressor of BMPR2 gene expression in experimental pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Circulating microRNA signature and its novel involvement in pathogenesis of chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 A novel murine model of severe pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 The role of fractalkine in idiopathic pulmonary arterial hypertension Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009